Equitec Proprietary Markets, LLC
- SEC CIK
- 0001143261
- Latest filing
- Jul 20, 2026
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by Equitec Proprietary Markets, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −12,200−100.0% | Sold out | Holders |
| Q3 2024 | 12,200 | $99.4K | 0.9% | −4,612−27.4% | ReducedConverted for a 1-for-40 split | Holders |
| Q2 2024 | 672,488 | $224.8K | 1.7% | 00.0% | Unchanged | Holders |
| Q1 2024 | 672,488 | $780.1K | 1.4% | −1,760,100−72.4% | Reduced | Holders |
| Q4 2023 | 2,432,588 | $4.11M | 4.4% | −95,500−3.8% | Reduced | Holders |
| Q3 2023 | 2,528,088 | $4.58M | 4.6% | −672,500−21.0% | Reduced | Holders |
| Q2 2023 | 3,200,588 | $5.95M | 4.2% | −445,062−12.2% | Reduced | Holders |
| Q1 2023 | 3,645,650 | $4.85M | 4.6% | −435,802−10.7% | Reduced | Holders |
| Q4 2022 | 4,081,452 | $6.90M | 4.0% | +1,795,187+78.5% | Added | Holders |
| Q3 2022 | 2,286,265 | $7.13M | 3.2% | −171,300−7.0% | Reduced | Holders |
| Q2 2022 | 2,457,565 | $5.85M | 2.7% | +795,109+47.8% | Added | Holders |
| Q1 2022 | 1,662,456 | $6.70M | 3.3% | +1,583,000+1,992.3% | Added | Holders |
| Q4 2021 | 79,456 | $660.0K | 0.4% | +79,456 | New | Holders |